强生宣布剥离骨科业务

格隆汇
Oct 14

跨国公司强生(JNJ)宣布,计划剥离骨科业务,以提升各公司的战略与运营聚焦度,并为股东创造价值。该交易将成立一家以DePuy Synthes之名独立运营的骨科业务公司。拆分完成后,强生将聚焦六个关键增长领域,即肿瘤学、免疫学、神经科学、心血管、外科和视力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10